Rochelle Walensky
#11,056
Most Influential Person Now
American medical scientist
Why Is Rochelle Walensky Influential?
(Suggest an Edit or Addition)According to Wikipedia, Rochelle Paula Walensky is an American physician-scientist who served as the director of the U.S. Centers for Disease Control and Prevention from 2021 to 2023 and had also served as the administrator of the Agency for Toxic Substances and Disease Registry in her capacity as the director of the U.S. Centers for Disease Control and Prevention from 2021 to 2023. On May 5, 2023, she announced her resignation, effective June 30, 2023. Prior to her appointment at the CDC, she had served as the chief of the Division of Infectious Diseases at Massachusetts General Hospital and a professor of medicine at Harvard Medical School. Walensky is an expert on HIV/AIDS.
Rochelle Walensky's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The survival benefits of AIDS treatment in the United States. (2006) (568)
- Expanded screening for HIV in the United States--an analysis of cost-effectiveness. (2005) (565)
- Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. (2009) (505)
- The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States (2006) (446)
- Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States (2020) (394)
- International AIDS Society global scientific strategy: towards an HIV cure 2016 (2016) (372)
- Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. (2012) (316)
- Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire. (2006) (272)
- HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. (2009) (266)
- Lifetime Medical Costs of Knee Osteoarthritis Management in the United States: Impact of Extending Indications for Total Knee Arthroplasty (2015) (259)
- Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa. (2003) (249)
- Impact of Obesity and Knee Osteoarthritis on Morbidity and Mortality in Older Americans (2011) (248)
- SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities. (2021) (237)
- The “ART” of Linkage: Pre-Treatment Loss to Care after HIV Diagnosis at Two PEPFAR Sites in Durban, South Africa (2010) (216)
- Expanded HIV Screening in the United States: Effect on Clinical Outcomes, HIV Transmission, and Costs (2006) (216)
- Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis. (2005) (212)
- Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. (2009) (200)
- Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions (2011) (189)
- Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study (2018) (187)
- Scientific consensus on the COVID-19 pandemic: we need to act now (2020) (185)
- Loss to Care and Death Before Antiretroviral Therapy in Durban, South Africa (2009) (170)
- Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. (2010) (169)
- When to start antiretroviral therapy in resource-limited settings. (2009) (157)
- Visual screening for malignant melanoma: a cost-effectiveness analysis. (2007) (143)
- Who starts antiretroviral therapy in Durban, South Africa?… not everyone who should (2010) (140)
- The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV (2008) (138)
- Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations. (2006) (135)
- From Mitigation to Containment of the COVID-19 Pandemic: Putting the SARS-CoV-2 Genie Back in the Bottle. (2020) (135)
- Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy. (2020) (129)
- Economic Savings Versus Health Losses: The Cost-Effectiveness of Generic Antiretroviral Therapy in the United States (2013) (129)
- Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC. (2010) (129)
- Routine human immunodeficiency virus testing: an economic evaluation of current guidelines. (2005) (128)
- Gender differences in research grant applications and funding outcomes for medical school faculty. (2008) (128)
- HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel. (2014) (125)
- Barriers to care among people living with HIV in South Africa: Contrasts between patient and healthcare provider perspectives (2013) (125)
- Routine HIV Screening in France: Clinical Impact and Cost-Effectiveness (2010) (121)
- Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. (2009) (120)
- Evaluation of the Cascade of Diabetes Care in the United States, 2005-2016. (2019) (118)
- Cost-effectiveness of HIV testing and treatment in the United States. (2007) (118)
- Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. (2003) (117)
- Routine Voluntary HIV Testing in Durban, South Africa: The Experience From an Outpatient Department (2007) (110)
- HIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programme (2009) (107)
- Tackling inpatient penicillin allergies: Assessing tools for antimicrobial stewardship (2017) (104)
- The Lifetime Medical Cost Savings From Preventing HIV in the United States (2015) (101)
- Scaling Up the 2010 World Health Organization HIV Treatment Guidelines in Resource-Limited Settings: A Model-Based Analysis (2010) (100)
- Integrating social contact and environmental data in evaluating tuberculosis transmission in a South African township. (2014) (97)
- The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women. (2012) (96)
- Lung Cancer Mortality Associated With Smoking and Smoking Cessation Among People Living With HIV in the United States (2017) (95)
- Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling Study. (2016) (93)
- Managing the Demand for Global Health Education (2011) (90)
- Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d’Ivoire: a trial-based analysis (2005) (89)
- Emergency provider attitudes and barriers to universal HIV testing in the emergency department. (2012) (88)
- All-Cause Excess Mortality and COVID-19-Related Mortality Among US Adults Aged 25-44 Years, March-July 2020. (2020) (87)
- Loss to follow-up in a community clinic in South Africa--roles of gender, pregnancy and CD4 count. (2011) (87)
- Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. (2012) (87)
- Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review (2014) (86)
- Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults (2012) (86)
- The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis (2012) (85)
- Cost-Effectiveness of Preventing Loss to Follow-up in HIV Treatment Programs: A Côte d'Ivoire Appraisal (2009) (84)
- Rapid HIV Testing at Home: Does It Solve a Problem or Create One? (2006) (82)
- Scaling up antiretroviral therapy in South Africa: the impact of speed on survival. (2008) (81)
- Integrating HIV screening into routine health care in resource-limited settings. (2010) (79)
- Identifying undiagnosed human immunodeficiency virus: the yield of routine, voluntary inpatient testing. (2002) (79)
- Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV. (2004) (77)
- The Cost of Penicillin Allergy Evaluation. (2017) (76)
- Linkage to HIV, TB and Non-Communicable Disease Care from a Mobile Testing Unit in Cape Town, South Africa (2013) (74)
- Risk Factors for Late-Stage HIV Disease Presentation at Initial HIV Diagnosis in Durban, South Africa (2013) (73)
- Improving Clinical Outcomes in Patients With Methicillin-Sensitive Staphylococcus aureus Bacteremia and Reported Penicillin Allergy. (2015) (71)
- What Will It Take to Eliminate Pediatric HIV? Reaching WHO Target Rates of Mother-to-Child HIV Transmission in Zimbabwe: A Model-Based Analysis (2012) (71)
- Linkage to care following community‐based mobile HIV testing compared with clinic‐based testing in Umlazi Township, Durban, South Africa (2014) (70)
- Covid-19: re-opening universities is high risk (2020) (67)
- The Clinical Impact and Cost-Effectiveness of Routine, Voluntary HIV Screening in South Africa (2011) (65)
- Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. (2013) (65)
- Refusing HIV testing in an urgent care setting: results from the "Think HIV" program. (2006) (64)
- Depressive Symptoms and Their Impact on Health-seeking Behaviors in Newly-diagnosed HIV-infected Patients in Durban, South Africa (2012) (64)
- Effective HIV case identification through routine HIV screening at urgent care centers in Massachusetts. (2005) (63)
- Revising Expectations from Rapid HIV Tests in the Emergency Department (2008) (63)
- Anaphylaxis after rechallenge with abacavir. (1999) (63)
- Projecting the benefits of antiretroviral therapy for HIV prevention: the impact of population mobility and linkage to care. (2012) (61)
- Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India. (2010) (61)
- US medical specialty global health training and the global burden of disease (2013) (61)
- HIV Testing Rates and Outcomes in a South African Community, 2001-2006: Implications for Expanded Screening Policies (2009) (61)
- Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy (2007) (60)
- Mobile HIV Screening in Cape Town, South Africa: Clinical Impact, Cost and Cost-Effectiveness (2014) (60)
- The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men. (2007) (59)
- Disease-modifying drugs for knee osteoarthritis: can they be cost-effective? (2009) (59)
- The Clinical and Economic Impact of Point-of-Care CD4 Testing in Mozambique and Other Resource-Limited Settings: A Cost-Effectiveness Analysis (2014) (58)
- Nomenclature and definitions for emergency department human immunodeficiency virus (HIV) testing: report from the 2007 conference of the National Emergency Department HIV Testing Consortium. (2009) (57)
- Routine HIV Screening in Portugal: Clinical Impact and Cost-Effectiveness (2012) (56)
- Laboratory Monitoring to Guide Switching Antiretroviral Therapy in Resource-Limited Settings: Clinical Benefits and Cost-Effectiveness (2010) (56)
- The impact of the President's Emergency Plan for AIDS Relief (PEPfAR) beyond HIV and why it remains essential. (2010) (55)
- The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States. (2016) (54)
- Filtration Efficiency, Effectiveness, and Availability of N95 Face Masks for COVID-19 Prevention. (2020) (53)
- Loss to Follow-Up and Mortality Among HIV-Infected People Co-Infected With TB at ART Initiation in Durban, South Africa (2012) (53)
- Counselor- versus provider-based HIV screening in the emergency department: results from the universal screening for HIV infection in the emergency room (USHER) randomized controlled trial. (2011) (53)
- Cost-effectiveness of World Health Organization 2010 Guidelines for Prevention of Mother-to-Child HIV Transmission in Zimbabwe (2012) (52)
- WHO 2010 Guidelines for Prevention of Mother-to-Child HIV Transmission in Zimbabwe: Modeling Clinical Outcomes in Infants and Mothers (2011) (52)
- The Impact of Reporting a Prior Penicillin Allergy on the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia (2016) (52)
- Routine HIV Testing in Adolescents and Young Adults Presenting to an Outpatient Clinic in Durban, South Africa (2012) (51)
- Clinical Impact and Cost-effectiveness of Diagnosing HIV Infection During Early Infancy in South Africa: Test Timing and Frequency. (2016) (48)
- Factors Associated with Refusal of Rapid HIV Testing in an Emergency Department (2010) (47)
- HIV Self-testing and the Missing Linkage (2011) (46)
- Cost-effectiveness of laboratory monitoring in sub-Saharan Africa: a review of the current literature. (2010) (45)
- Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa. (2008) (45)
- Quantification of Shared Air: A Social and Environmental Determinant of Airborne Disease Transmission (2014) (44)
- Home testing for HIV infection in resource-limited settings (2009) (44)
- Sizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South Africa (2016) (44)
- The impact of active mentorship: results from a survey of faculty in the Department of Medicine at Massachusetts General Hospital (2018) (43)
- The Survival Benefits of Antiretroviral Therapy in South Africa (2013) (43)
- Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed hiv-infected adults: a prospective, clinic-based study (2014) (42)
- Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States (2017) (41)
- Discontinuation of contact precautions for methicillin-resistant staphylococcus aureus: a randomized controlled trial comparing passive and active screening with culture and polymerase chain reaction. (2013) (40)
- Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials. (2012) (40)
- Optimal Allocation of Testing Dollars: The Example of HIV Counseling, Testing, and Referral (2005) (40)
- Screening for acute HIV infection in South Africa: finding acute and chronic disease * (2011) (39)
- TREATMENT FOR PRIMARY HIV INFECTION: PROJECTING OUTCOMES OF IMMEDIATE, INTERRUPTED, OR DELAYED THERAPY (2002) (39)
- Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection (2015) (38)
- The Anticipated Clinical and Economic Effects of 909090 in South Africa (2016) (38)
- The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa. (2013) (37)
- Cost-Effectiveness of Enfuvirtide in Treatment-Experienced Patients With Advanced HIV Disease (2005) (37)
- The association between HIV and atherosclerotic cardiovascular disease in sub-Saharan Africa: a systematic review (2017) (36)
- Disease Control Priorities, Third Edition (Volume 6): Major Infectious Diseases (2017) (36)
- Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity (2008) (36)
- Potential savings by reduced CD4 monitoring in stable patients with HIV receiving antiretroviral therapy. (2013) (35)
- Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial (2012) (35)
- Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South Africa (2016) (35)
- Finding HIV in Hard to Reach Populations: Mobile HIV Testing and Geospatial Mapping in Umlazi Township, Durban, South Africa (2015) (34)
- The clinical role and cost-effectiveness of long-acting antiretroviral therapy. (2015) (34)
- Does Modality of Survey Administration Impact Data Quality: Audio Computer Assisted Self Interview (ACASI) Versus Self-Administered Pen and Paper? (2010) (33)
- The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis (2017) (33)
- Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential (2019) (32)
- Serosurveillance and the COVID-19 Epidemic in the US: Undetected, Uncertain, and Out of Control. (2020) (32)
- The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial. (2013) (32)
- Charting the Future of Infectious Disease: Anticipating and Addressing the Supply and Demand Mismatch. (2017) (32)
- Home HIV Testing: Good News but Not a Game Changer (2012) (32)
- Positive Epstein-Barr virus heterophile antibody tests in patients with primary human immunodeficiency virus infection. (2001) (32)
- Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age (2015) (31)
- Peripheral blood eosinophilia and hypersensitivity reactions among patients receiving outpatient parenteral antibiotics. (2015) (30)
- Validation and Calibration of a Computer Simulation Model of Pediatric HIV Infection (2013) (30)
- Therapeutic Drug Monitoring in HIV Treatment: A Literature Review (2006) (30)
- The Cost-Effectiveness of Tuberculosis Preventive Therapy for HIV-Infected Individuals in Southern India: A Trial-Based Analysis (2012) (29)
- Quantifying the risks and benefits of efavirenz use in HIV‐infected women of childbearing age in the USA (2011) (28)
- HIV drug resistance surveillance for prioritizing treatment in resource-limited settings (2007) (28)
- The impact of HIV/HCV co‐infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort (2011) (28)
- Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study. (2019) (28)
- Clinical effect and cost-effectiveness of incorporation of point-of-care assays into early infant HIV diagnosis programmes in Zimbabwe: a modelling study. (2019) (27)
- Modeling and Cost-Effectiveness in HIV Prevention (2016) (27)
- Clinical Impact and Cost-Effectiveness of Expanded Voluntary HIV Testing in India (2013) (27)
- Factors Associated with Self-Reported Repeat HIV Testing after a Negative Result in Durban, South Africa (2013) (26)
- Recorded Penicillin Allergy and Risk of Mortality: a Population-Based Matched Cohort Study (2019) (26)
- First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial (2011) (26)
- Expanded HIV screening in the United States: what will it cost government discretionary and entitlement programs? A budget impact analysis. (2010) (26)
- A randomized trial to optimize HIV/TB care in South Africa: design of the Sizanani trial (2013) (26)
- Assessing the impact of federal HIV prevention spending on HIV testing and awareness. (2006) (26)
- The Linkage Outcomes of a Large-scale, Rapid Transfer of HIV-infected Patients From Hospital-based to Community-based Clinics in South Africa (2014) (25)
- Could Early Antiretroviral Therapy Entail More Risks than Benefits in Sub-Saharan African HIV-Infected Adults? A Model-Based Analysis (2013) (24)
- Optimal Frequency of Cd4 Cell Count and HIV Rna Monitoring Prior to Initiation of Antiretroviral Therapy in HIV-Infected Patients (2005) (23)
- Where Is the ID in COVID-19? (2020) (23)
- A therapeutic HIV vaccine: how good is good enough? (2004) (23)
- Rapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalized patients in Africa (the STAMP trial): study protocol for a randomised controlled trial (2016) (23)
- Should We Be Testing for Baseline Integrase Resistance in Patients Newly Diagnosed With Human Immunodeficiency Virus? (2017) (23)
- The cost‐effectiveness of HIV pre‐exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil (2018) (22)
- CDC Interim Recommendations for Fully Vaccinated People: An Important First Step. (2021) (22)
- Rethinking the Ban - The U.S. Blood Supply and Men Who Have Sex with Men. (2017) (22)
- Survival benefits of antiretroviral therapy in Brazil: a model-based analysis (2016) (22)
- Development, Calibration and Performance of an HIV Transmission Model Incorporating Natural History and Behavioral Patterns: Application in South Africa (2014) (22)
- AIDS Drug Assistance Programs: highlighting inequities in human immunodeficiency virus-infection health care in the United States. (2002) (21)
- Insurance coverage and financing landscape for HIV treatment and prevention in the USA (2021) (21)
- Investigation of primary human immunodeficiency virus infection in patients who test positive for heterophile antibody. (2001) (21)
- An electronic surveillance tool for catheter-associated urinary tract infection in intensive care units. (2015) (21)
- Where Were the Women? Gender Parity in Clinical Trials. (2019) (20)
- Cost-effectiveness of HIV interventions: from cohort studies and clinical trials to policy. (2009) (20)
- Implementing a Routine, Voluntary HIV Testing Program in a Massachusetts County Prison (2006) (20)
- HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy? (2014) (20)
- National Survey of Infection Preventionists: Policies for Discontinuation of Contact Precautions for Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus (2012) (20)
- Effectiveness of first-line antiretroviral therapy in the IPEC cohort, Rio de Janeiro, Brazil (2014) (20)
- The Clinical and Economic Impact of Attaining National HIV/AIDS Strategy Treatment Targets in the United States (2017) (20)
- Clinic-Based Routine Voluntary HIV Testing in a Refugee Settlement in Uganda (2014) (19)
- Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential A Modeling Study (2019) (19)
- Patient satisfaction with rapid HIV testing in the emergency department. (2011) (19)
- Resource Burden Associated with Contact Precautions for Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: The Patient Access Managers' Perspective (2012) (19)
- COVID-19 screening strategies that permit the safe re-opening of college campuses (2020) (19)
- HIV Antiretroviral Therapy Costs in the United States, 2012-2018. (2020) (19)
- Routine, voluntary HIV testing in Durban, South Africa: correlates of HIV infection * (2008) (19)
- Missed Opportunities for Measles, Mumps, Rubella Vaccination Among Departing U.S. Adult Travelers Receiving Pretravel Health Consultations (2017) (19)
- Case records of the Massachusetts General Hospital. Case 39-2006. A 24-year-old woman with systemic lupus erythematosus, seizures, and right arm weakness. (2006) (18)
- Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid (2017) (18)
- Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age (2012) (18)
- Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire. (2006) (18)
- High Frequency of Hypothalamic-Pituitary-Adrenal Axis Dysfunction After Local Corticosteroid Injection in HIV-Infected Patients on Protease Inhibitor Therapy (2013) (18)
- Comparative Pricing of Branded Tenofovir Alafenamide–Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate–Emtricitabine for HIV Preexposure Prophylaxis (2020) (18)
- The long‐term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model‐based approach (2007) (17)
- Cost-Effectiveness of HIV Testing Referral Strategies among Tuberculosis Patients in India (2010) (17)
- The Optimal Age for Screening Adolescents and Young Adults Without Identified Risk Factors for HIV. (2018) (17)
- The cost‐effectiveness and budgetary impact of a dolutegravir‐based regimen as first‐line treatment of HIV infection in India (2018) (17)
- Estimating Shortages in Capacity to Deliver Continuous Kidney Replacement Therapy During the COVID-19 Pandemic in the United States (2020) (17)
- Intradermal Vaccination for Monkeypox - Benefits for Individual and Public Health. (2022) (16)
- The Epi-TAF for Tenofovir Disoproxil Fumarate? (2016) (16)
- High-cost, high-need patients: the impact of reported penicillin allergy. (2020) (16)
- Association Between Penicillin Allergy Documentation and Antibiotic Use. (2020) (16)
- Access to Medications and Medical Care After Participation in HIV Clinical Trials: A Systematic Review of Trial Protocols and Informed Consent Documents (2009) (16)
- Penicillin Allergy Evaluation Access: A National Survey. (2020) (16)
- Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies. (2016) (15)
- Point-of-Care CD4 Testing to Inform Selection of Antiretroviral Medications in South African Antenatal Clinics: A Cost-Effectiveness Analysis (2015) (15)
- A Case Series of 59 Patients with Nocardiosis (2001) (15)
- Relationship Between Upper Respiratory Tract Influenza Test Result and Clinical Outcomes Among Critically Ill Influenza Patients (2016) (15)
- Rapid HIV testing program implementation: lessons from the emergency department (2009) (15)
- Clinical impact and cost-effectiveness of genotype testing at HIV diagnosis in the United States. (2020) (15)
- The Acceptability and Feasibility of Routine Pediatric HIV Testing in an Outpatient Clinic in Durban, South Africa (2013) (15)
- Global Health Training in US Graduate Psychiatric Education (2014) (14)
- Resource Utilization and Cost-Effectiveness of Counselor- vs. Provider-Based Rapid Point-of-Care HIV Screening in the Emergency Department (2011) (14)
- Optimizing resource allocation in United States AIDS drug assistance programs. (2006) (14)
- Cost-Effectiveness of Genotype Testing for Primary Resistance in Brazil (2015) (14)
- Frequent HIV testing among participants of a routine HIV testing program (2010) (14)
- Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States (2022) (14)
- The HIV cure research agenda: the role of mathematical modelling and cost-effectiveness analysis (2015) (14)
- Cost-effectiveness analysis and HIV screening: the emergency medicine perspective. (2011) (14)
- Challenges in evaluating the cost-effectiveness of new diagnostic tests for HIV-associated tuberculosis. (2013) (13)
- Effectiveness of antiretroviral therapy after protease inhibitor failure: an analytic overview. (2004) (13)
- Improving Outcomes in State AIDS Drug Assistance Programs (2009) (13)
- Expanding provider-initiated HIV testing at STI clinics in China (2012) (13)
- Clinical and Economic Impact of Ibalizumab for People With Multidrug-Resistant HIV in the United States. (2020) (13)
- Call to action: how can the US Ending the HIV Epidemic initiative succeed? (2021) (13)
- Cardiovascular risk factors among ART‐experienced people with HIV in South Africa (2019) (13)
- Testing for HIV infection in the United States (2007) (13)
- The Clinical and Economic Impact of Point-of-Care CD 4 Testing in Mozambique and Other Resource-Limited Settings : A Cost-Effectiveness Analysis (2014) (12)
- Treatment Delays Associated With Prior Authorization for Infusible Medications: A Cohort Study (2020) (12)
- CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: Projecting beyond clinical trials (2010) (12)
- The Cost-effectiveness of HIV Pre-exposure Prophylaxis and HIV Testing Strategies in High-risk Groups in India. (2020) (12)
- The Challenges Ahead With Monoclonal Antibodies: From Authorization to Access. (2020) (12)
- HIV/AIDS: AIDS Drug Assistance Programs in the era of routine HIV testing. (2008) (12)
- Scope of Global Health Training in U.S. Obstetrics and Gynecology Residency Programs (2013) (12)
- The outcome and impact of 10 years of HAART (2008) (11)
- Assessment of Job Satisfaction and Feeling Valued in Academic Medicine. (2019) (11)
- Optimizing treatment for HIV-infected South African women exposed to single-dose nevirapine: balancing efficacy and cost. (2006) (11)
- The epi-TAF for TDF? (2015) (11)
- The Impact of Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococcus (VRE) Flags on Hospital Operations (2016) (10)
- Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis (2020) (10)
- Late diagnosis of HIV infection at two academic medical centers: 1994–2004 (2008) (10)
- Concordance of PCR and Culture from Nasal Swabs for Detection of Methicillin-Resistant Staphylococcus aureus in a Setting of Concurrent Antistaphylococcal Antibiotics (2014) (10)
- Feasibility and acceptability of home-based HIV testing among refugees: a pilot study in Nakivale refugee settlement in southwestern Uganda (2018) (10)
- Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results (2020) (10)
- Predictors of HIV infection: a prospective HIV screening study in a Ugandan refugee settlement (2016) (10)
- Estimation of the Prevalence of Undiagnosed and Diagnosed HIV in an Urban Emergency Department (2011) (10)
- The cascade of HIV care among refugees and nationals in Nakivale Refugee Settlement in Uganda (2017) (10)
- Acceptability of fingerstick versus oral fluid rapid HIV testing: results from the universal screening for HIV infection in the emergency room (USHER Phase II) randomized controlled trial. (2012) (9)
- Combination HIV Prevention: The Value and Interpretation of Mathematical Models (2013) (9)
- Impact of rapid screening for discontinuation of methicillin-resistant Staphylococcus aureus contact precautions. (2016) (9)
- Implications and impact of the new US centers for disease control and prevention HIV testing guidelines (2008) (9)
- The Costs of Drugs in Infectious Diseases: Branded, Generics, and Why We Should Care. (2019) (8)
- Drug-Resistant Tuberculosis among HIV-Infected Patients Starting Antiretroviral Therapy in Durban, South Africa (2012) (8)
- One Year of COVID-19 Vaccines: A Shot of Hope, a Dose of Reality. (2021) (8)
- New USPSTF Guidelines for HIV Screening and Preexposure Prophylaxis (PrEP): Straight A's. (2019) (8)
- Individualizing the WHO HIV and infant feeding guidelines: optimal breastfeeding duration to maximize infant HIV-free survival (2014) (8)
- Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis (2020) (8)
- The Clinical Impact and Cost-effectiveness of MMR Vaccination to Prevent Measles Importations among US International Travelers. (2018) (8)
- Cost-effectiveness of integrating postpartum antiretroviral therapy and infant care into maternal & child health services in South Africa (2019) (8)
- Coronavirus Disease 2019 (COVID-19) Diagnostic Clinical Decision Support: A Pre-Post Implementation Study of CORAL (COvid Risk cALculator) (2021) (8)
- Cost-effectiveness of frequent HIV screening among high-risk young men who have sex with men in the United States. (2020) (7)
- Development and Validation of PREDICT-DM: A New Microsimulation Model to Project and Evaluate Complications and Treatments of Type 2 Diabetes Mellitus. (2019) (7)
- Implementing Generalized Additive Models to Estimate the Expected Value of Sample Information in a Microsimulation Model: Results of Three Case Studies (2017) (7)
- Acceptability of Fingerstick Versus Oral Fluid Rapid HIV Testing: Results From the Universal Screening for HIV Infection in the Emergency Room (USHER Phase II) Randomized Controlled Trial (2012) (7)
- Projected Survival Gains from Revising State Laws Requiring Written Opt-in Consent for HIV Testing (2011) (7)
- A Discrete Event Simulation Model of Patient Flow in a General Hospital Incorporating Infection Control Policy for Methicillin-Resistant Staphylococcus Aureus (MRSA) and Vancomycin-Resistant Enterococcus (VRE) (2017) (7)
- Cost-Effectiveness of Generic Antiretroviral Therapy (2013) (6)
- Has Pre-exposure Prophylaxis Made a Difference at a Population Level? Jury Is Still Out. (2020) (6)
- HIV testing rates, prevalence, and knowledge among outpatients in Durban, South Africa: Time trends over four years (2015) (6)
- Novel microsimulation model of tobacco use behaviours and outcomes: calibration and validation in a US population (2020) (6)
- Increasing Operational Capacity and Reducing Costs of Rituximab Administration: A Costing Analysis (2020) (6)
- Effectiveness and Cost-Effectiveness of Treatment as Prevention for HIV (2017) (6)
- Cost-effectiveness of a Novel Lipoarabinomannan Test for Tuberculosis in Patients With Human Immunodeficiency Virus (2020) (6)
- Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa (2017) (6)
- Respiratory Symptom Incidence Among People Using Electronic Cigarettes, Combustible Tobacco, or Both. (2021) (6)
- Developing and Validating Metamodels of a Microsimulation Model of Infant HIV Testing and Screening Strategies Used in a Decision Support Tool for Health Policy Makers (2020) (6)
- Optimal breastfeeding durations for HIV‐exposed infants: the impact of maternal ART use, infant mortality and replacement feeding risk (2018) (6)
- Clinical impact and cost-effectiveness of early infant HIV diagnosis in South Africa : Test timing and frequency (2016) (5)
- Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. (2014) (5)
- Using national laboratory data to assess cumulative frequency of linkage after transfer to community‐based HIV clinics in South Africa (2019) (5)
- Housestaff Knowledge Related to Urinary Catheter Use and Catheter-Associated Urinary Tract Infections (2015) (5)
- Investing in People Who Inject Drugs: A PrEPonderance of Opportunities (2016) (5)
- The Impact of the 2013 WHO Antiretroviral Therapy Guidelines on the Feasibility of HIV Population Prevention Trials (2014) (5)
- Focusing National Institutes of Health HIV/AIDS research for maximum population impact. (2015) (5)
- Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d’Ivoire: A model-based analysis (2019) (5)
- O113 HIV-1 clade C resistance genotypes after first virological failure in a large community ART programme (2008) (5)
- 745Risk of Peripheral Blood Eosinophilia and Hypersensitivity Reactions among Patients Receiving Outpatient Parenteral Antibiotics (2014) (5)
- Clinical Practices for Measles-Mumps-Rubella Vaccination Among US Pediatric International Travelers. (2019) (5)
- HIV Testing After a First Positive Rapid Diagnostic Test: A Role for Nucleic Acid Testing? (2018) (5)
- Prevalence and correlates of clinically significant depressive symptoms in an urban hospital emergency department. (2010) (5)
- Clinical Impact and Cost-Effectiveness of Making Third-Line Antiretroviral Therapy Available in Sub-Saharan Africa: A Model-Based Analysis in Côte d'Ivoire (2014) (4)
- Diet, physical activity, and obesity among ART-experienced people with HIV in South Africa (2021) (4)
- Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
- Comparative Pricing of Branded Tenofovir Alafenamide–Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate–Emtricitabine for HIV Preexposure Prophylaxis (2020) (4)
- Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US (2015) (4)
- Payments for Preexposure Prophylaxis in the United States: Too Much for Too Few (2020) (4)
- 376: The Barriers Affecting Health Care Providers’ Willingness to Perform Routine HIV Testing in the Emergency Department (2007) (4)
- The Dynamics of Infectious Diseases Associated With Injection Drug Use in Lawrence and Lowell, Massachusetts (2021) (3)
- Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India (2018) (3)
- The value of point-of-Care CD4 and Laboratory viral Load in tailoring ART monitoring Strategies to resource limitations. (2017) (3)
- Missed Opportunities: Refusal to Confirm Reactive Rapid HIV Tests in the Emergency Department (2013) (3)
- Mortality among Adults Ages 25-44 in the United States During the COVID-19 Pandemic. (2020) (3)
- Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documents. (2009) (3)
- A cohort study to assess a communication intervention to improve linkage to HIV care in Nakivale Refugee Settlement, Uganda (2020) (2)
- A novel method to estimate the indirect community benefit of HIV interventions using a microsimulation model of HIV disease (2020) (2)
- Modeling Adherence Interventions Among Youth with HIV in the United States: Clinical and Economic Projections (2021) (2)
- The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations. (2017) (2)
- The Association Between Symptoms and COVID-19 Test Results Among Healthcare Workers (2020) (2)
- Shortened Tuberculosis Treatment for People with HIV in South Africa: A Model-based Evaluation and Cost-effectiveness Analysis. (2020) (2)
- Adolescent Linkage to Care After a Large-scale Transfer From a Hospital-based HIV Clinic to the Public Sector in South Africa (2016) (2)
- What is a modest public health impact? (2012) (2)
- Addressing Antibiotic Overuse in the Outpatient Setting: Lessons From Behavioral Economics. (2021) (2)
- Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus (2019) (2)
- Outcomes from an infectious disease physician-guided evaluation of hospitalized persons under investigation for coronavirus disease 2019 (COVID-19) at a large US academic medical center (2020) (2)
- Editorial Commentary: Age-Old Questions: When to Start Antiretroviral Therapy and in Whom? (2015) (2)
- Monitoring of antiretroviral therapy in low-resource settings (2008) (2)
- Please Pass the Peanut Butter. (2017) (1)
- 212 The Refugee Cascade of Care: Prospective Assessment Reveals Attrition From HIV Care in Nakivale Refugee Settlement in Uganda (2015) (1)
- Reply to ‘Declining adherence as a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial’ (2012) (1)
- Loss to Follow-Up Worsens Outcomes for HIV Patients, Even If They Return to Care (2009) (1)
- Association of Penicillin Allergy Documentation and Antibiotic Use: A National Inpatient Study (2020) (1)
- Expanded HIV Screening in the U.S.: What Will It Cost Government Discretionary and Entitlement Programs? A Budget Impact Analysis (2010) (1)
- Track C Epidemiology and Prevention Science (2012) (1)
- APTIMA assay approved for HIV testing. (2006) (1)
- Improving Antibiotic Choice in Hospitalized Medical Patients Reporting Penicillin Allergy (2017) (1)
- Partnerships, Collaborations, and Investments Integral to CDC’s International Response to COVID-19 (2022) (1)
- Implementing Routine HIV Testing: The Role of State Law (2007) (1)
- Photo quiz. An HIV-infected man with an upset stomach. (2008) (1)
- Track E Implementation Science, Health Systems and Economics (2012) (1)
- Track E Implementation Science, Health Systems and Economics (2012) (1)
- Track E Implementation Science, Health Systems and Economics (2012) (1)
- Vesiculopapular rash. (2006) (1)
- 355 DISEASE MODIFYING DRUGS IN KNEE OSTEOARTHRITIS: CAN THEY BE COST-EFFECTIVE? (2009) (0)
- HIV and Cost Considerations - Entering a New Era (2017) (0)
- The Cost of Our Drugs: Branded, Generics and Why We Should Care (2018) (0)
- Can We Get Even More Bang from TNT (2010) (0)
- The Survival Benefits of AIDS Treatment in the United States (2006) (0)
- 344-OR: Persistent Treatment Gaps and Disparities in U.S. Diabetes Mellitus Care in 2005-2016 (2019) (0)
- Improving the Cascades of HIV Care (2014) (0)
- Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: A Randomized Controlled Trial (2014) (0)
- A novel microsimulation model of chronic hepatitis B (HBV): validation of HBV viral dynamics and cumulative incidence of hepatocellular carcinoma (2020) (0)
- Implications and Impact of the Centers for Disease Control and Prevention (CDC) New HIV Testing Guidelines (2012) (0)
- A piece of my mind. Disclosure. (2010) (0)
- Misinterpretation of HIV preexposure prophylaxis findings. (2014) (0)
- A New Paradigm: Routine HIV Testing (2006) (0)
- Audio Interview: Covid-19 Vaccines and Pregnancy - A Conversation with CDC Director Rochelle Walensky. (2021) (0)
- Pretravel Assessment of Measles Immunity Status and Administration of Measles-Mumps-Rubella for Adult International Travelers Seen in Global TravEpiNet Sites (2015) (0)
- ART as a Preventive Intervention (2008) (0)
- 319A discrete event simulation (DES) model of patient flow incorporating infection control policy for vancomycin-resistant Enterococcus (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) (2014) (0)
- Impact of Expanded HIV Screening (2007) (0)
- In reply. (2014) (0)
- Evaluating Point-of-Care Nucleic Acid Tests in Adult Human Immunodeficiency Virus Diagnostic Strategies: A Côte d’Ivoire Modeling Analysis (2021) (0)
- Media statement from Rochelle P. Walensky, MD, MPH, in observance of one-year pandemic milestone (2021) (0)
- Gratitude for Public Health: COVID-19 and Beyond (2023) (0)
- PrEP in MSM: Enough Bang for the Buck? (2012) (0)
- ImplementingRapidHIVTestingWithorWithout Risk-ReductionCounselinginDrugTreatmentCenters: ResultsofaRandomizedTrial (2012) (0)
- Further Limitations of a Model-Based Study of People Living With HIV and Lung Cancer Mortality-Reply. (2018) (0)
- HIV Clinical State-of-the-Art (2014) (0)
- Is ART for Treatment and Prevention a Win–Win? (2012) (0)
- Reply to Spellberg, Fuchs, and Manian. (2017) (0)
- TUPDC0103: Gonorrhea infections diagnosed among persons living with HIV: cross matching surveillance registries to identify potential opportunities for integrated partner services-New York City, Washington D.C., Miami/Dade County and Arizona (2012) (0)
- 2769. The Clinical and Economic Impact of MMR Vaccinations to Prevent Measles Importations from US Pediatric Travelers Returning from Abroad (2019) (0)
- Point-of-Care CD 4 Testing to Inform Selection of Antiretroviral Medications in South African Antenatal Clinics : A Cost-Effectiveness Analysis (2015) (0)
- Routine HIV screening in France: an estimation of clinical impact and cost-effectiveness. (2010) (0)
- HMS Task Force on Faculty Development and Diversity (2010) (0)
- The Blood Supply and Men Who Have Sex with Men. (2017) (0)
- 1286. Evaluating Strategies to Reduce Risk of HIV Infection in the US Blood Supply (2018) (0)
- Survival Benefits of Retention in HIV Care (2007) (0)
- Evaluating point-of-care nucleic acid tests in adult HIV diagnostic strategies: a Côte d’Ivoire modeling analysis (2021) (0)
- 313Value of Discontinuation of Contact Precautions (CP) for Methicillin-Resistant Staphylococcus aureus (MRSA) (2014) (0)
- Cost-Effectiveness of Alternative HIV Screening Strategies for Young Men WHO Have Sex with Men in the United States (2018) (0)
- Impact of expanded HIV screening. Authors' reply (2007) (0)
- The Clinical and Economic Impact of Measles-Mumps-Rubella Vaccinations to Prevent Measles Importations From US Pediatric Travelers Returning From Abroad (2022) (0)
- Do HIV Testing Rates Improve When Written Consent Is No Longer Required (2007) (0)
- Track B Clinical Science (2012) (0)
- Decreased Progression To Active Tuberculosis Following Re-Infection With M. Tuberculosis (2011) (0)
- Therapeutic Drug Monitoring in HIV Treatment: A Literature Review (2006) (0)
- The increased risk of methicillin-resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy (2018) (0)
- Screening Adolescents and Young Adults for HIV in the United States: A Cost-Effectiveness Analysis (2017) (0)
- Too Few HIV-Infected Patients Are Receiving Care (2009) (0)
- The impact of active mentorship: results from a survey of faculty in the Department of Medicine at Massachusetts General Hospital (2018) (0)
- 290Optimizing clinical outcomes in patients with methicillin-sensitive Staphylococcus aureus bacteremia and reported penicillin allergy (2014) (0)
- Penicillin Allergy Evaluation Access in US Hospitals: A Survey (2020) (0)
- Predictors of HIV-infection during routine clinic-based HIV testing in Nakivale Refugee settlement in SW Uganda (2015) (0)
- Limitations of Rapid Testing (2007) (0)
- Gender Parity in Clinical PrEP Trials. Reply. (2019) (0)
- Erratum to: Rapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalized patients in Africa (the STAMP trial): study protocol for a randomised controlled trial (2016) (0)
This paper list is powered by the following services:
Other Resources About Rochelle Walensky
What Schools Are Affiliated With Rochelle Walensky?
Rochelle Walensky is affiliated with the following schools:
